Study identifies EGFR–CDCP1 as co-target pair to enhance tumour killing
Researchers define a proximity-mapping atlas revealing disease-associated membrane spatial communities and identify EGFR–CDCP1 as a co-target pair that enhances tumour killing by multispecific therapeutics.
This story has stopped developing; this page is its permanent record. More from that day
Sources
Every article we clustered into this story. Headlines link to the publisher.
In this story
- EGFR
- CDCP1